65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Ended Awarded Last action

Contract number
36F79718D0456
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • M5Q50A03R7 Solicitation number
Last date to order 100% complete
IDV ceiling
$4,200,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The U.S. Department of Veterans Affairs National Acquisition Center has awarded a Federal Supply Schedule (FSS) contract to Melinta Therapeutics, LLC, a for-profit manufacturer of pharmaceutical products. The contract, identified as 36F79718D0456, is under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and has a ceiling value of $4,200,000.00 with an ultimate completion date of September 1, 2024.

Additionally, the VA has issued a Blanket Purchase Agreement (BPA) under this FSS contract, with a unique identifier of 36F79718D0456|36E79724A0014. The BPA has a ceiling value of $500,000.00 and a last date to order of April 24, 2025. The BPA is for the procurement of the pharmaceutical product REZZAYO, establishing pre-negotiated terms, conditions, and prices for the VA to order the product on an as-needed basis. Both the FSS contract and the BPA were awarded with no set-aside used, and the prime contractor, Melinta Therapeutics, LLC, is a for-profit organization and manufacturer of the contracted goods.

IDV awards

IDV Agency Ceiling Awarded
36E79724A0014 BPA for rezzayo National Acquisition Center (VA) $500,000

Transactions

Action Obligated Date
Legal Contract Cancellation P00030 · Contract cancellation $0
Supplemental Agreement for work within scope P00029 $0
Supplemental Agreement for work within scope P00028 · Short term extension $0
Supplemental Agreement for work within scope P00026 · Public law lifecycle $0
Supplemental Agreement for work within scope P00027 · Administrative change $0
Supplemental Agreement for work within scope P00025 · Temporary price reduction $0
Supplemental Agreement for work within scope P00024 · Public law 2024 pricing updates $0
Supplemental Agreement for work within scope P00023 · Addition $0
Supplemental Agreement for work within scope P00022 · NDC change $0
Supplemental Agreement for work within scope P00021 $0
Supplemental Agreement for work within scope P00020 · Short term extension $0
Supplemental Agreement for work within scope P00019 · Public law 2023 updates $0
Supplemental Agreement for work within scope P00018 · Addition $0
Supplemental Agreement for work within scope P00017 · Temporary price reduction $0
Supplemental Agreement for work within scope P00016 · Lifecycle change $0
Supplemental Agreement for work within scope P00015 · Public law 2022 $0
Supplemental Agreement for work within scope P00014 · Addition $0
Vendor DUNS or Name Change - Non-Novation P00013 · Name change $0
Other Administrative Action P00012 · Admin-POC change $0
Supplemental Agreement for work within scope P00010 · Temporary price reduction $0
Supplemental Agreement for work within scope P00009 · 65IB: drugs, pharmaceuticals and hematology related products - 2021 public law $0
Supplemental Agreement for work within scope P00008 · Public law annual pricing updates $0
Supplemental Agreement for work within scope P00007 · 65IB: drugs, pharmaceuticals and hematology related products - PL life cycle change $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 · 65IB: drugs, pharmaceuticals and hematology related products - product addition $0
Supplemental Agreement for work within scope P00003 · 65IB: drugs, pharmaceuticals and hematology related products - 2019 public law $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · 65IB: drugs, pharmaceuticals and hematology related products - administrative point of contact for contract administration and IFF/sales report change $0
Original award $0
Show all 30

Quick answers

Who was awarded contract 36F79718D0456?

36F79718D0456 was awarded to Melinta Therapeutics, LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on June 15, 2018.

How much is contract 36F79718D0456 worth?

36F79718D0456's own ceiling is $4,200,000.

Who can order from contract 36F79718D0456?

36F79718D0456 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79718D0456 part of a contract vehicle?

Yes. 36F79718D0456 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79718D0456 competed?

The extent of competition for 36F79718D0456 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV